A quantum leap in prostate imaging

The Facts

Prostate Cancer is the most commonly diagnosed cancer among North American men - an esitimated 25% of all new cancer cases
In 2013, 23,600 Canadian men will be diagnosed with prostate cancer; 3,900 will die from the disease1
In 2013, 239,000 American men will be diagnosed with prostate cancer, over 29,000 will die from the disease2
Poor ultrasound imaging leads to incorrect diagnosis and treatment
   

Imagistx Solution

Adapted the world’s leading ultra-high frequency pre-clinical ultrasound machine to the human prostate
Very successful Pilot Study conducted at Johns Hopkins. Click here for peer-reviewed publication
Starting multi-site, randomized-controlled clinical study at five sites across North America
   

For additional information contact info@imagistxprostate.com

 

"HiTRUS appears promising for prostate cancer imaging. Our initial experience suggests superiority to LoTRUS for the visualization of cancerous foci, and supports proceeding with a clinical trial in the biopsy setting."

Conclusion of Pilot Study at
Johns Hopkins Medical Center
Click here for peer-reviewed publication